Overview

Detailed Summary

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients and operates through four divisions. It has five manufacturing facilities across India, enjoying numerous global certifications.
The company has a rich history of collaborations and initiatives, having set up various R&D centers and strategic plants since its inception in 1962, illustrating its commitment to growth and innovation.
Recent strategic moves include a significant acquisition by Ipca Laboratories Limited, which now holds majority control over Unichem, influencing its future trajectory and operational strategies.
Despite divesting some business components in the past, Unichem continues to expand its international presence, notably with a wholly owned subsidiary in China, reflecting its global ambitions.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 3,797 Cr
Volatility: Low Risk
P/E Ratio: 46.4
Industry P/E: 36.7
PEG Ratio: -1.1
P/B Ratio: 1.4
52W High: 685.95
52W Low: 280.00

Sales CAGR

1Y: 4.31%
3Y: 9.61%
5Y: 4.67%
10Y: 10.46%

Profit CAGR

1Y: 83.86%
3Y: —
5Y: 24.06%
10Y: —

ROE

TTM: 2.88%
3Y: 3.90%
5Y: 1.01%
10Y: 11.33%

ROCE

TTM: 3.79%
3Y: 5.49%
5Y: 2.31%
10Y: 0.28%

Technicals

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ZOTA		1258.40	4,358 Cr	—	6.28	0.08	-10.66	-6.48	-6.55
NOVARTIND		1657.35	4,067 Cr	41.60	4.97	0.00	11.39	15.94	9.99
GUJTHEM		360.50	3,928 Cr	84.23	13.65	0.19	16.22	14.47	9.27
UNICHEMLAB		539.90	3,797 Cr	46.37	1.40	0.00	2.88	3.79	6.77
GUFICBIO		377.85	3,793 Cr	59.10	5.70	0.03	9.66	11.45	4.78
AARTIDRUGS		405.05	3,693 Cr	18.94	2.38	0.49	12.58	11.51	6.92
SMSPHARMA		386.60	3,566 Cr	34.97	4.54	0.11	12.98	12.14	6.46
Median: 7 Co.	—	405.05	3,797 Cr	43.98	4.97	0.08	11.39	11.51	6.77

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	434	432	446	462	533	587	527	579	521	575
Expenses	396	406	403	405	448	503	504	513	476	527
Operating Profit	38	25	44	58	86	84	22	66	45	48
OPM %	8.78	5.87	9.74	12.45	16.04	14.25	4.27	11.43	8.59	8.29
Other Income	79	-119	3.86	8.79	14	9.25	6.82	-37	287	11
Interest	5.58	4.59	4.03	4.79	6.75	5.46	6.54	8.24	7.42	9.39
Depreciation	28	27	28	29	31	30	32	31	31	31
Profit Before Tax	84	-126	15	33	62	58	-9.02	-11	293	19
Tax %	-0.02	-2.73	38.27	7.58	6.47	8.36	-16.08	-9.89	9.93	41.94
Net Profit	84	-129	9.26	30	58	53	-10	-12	264	11
EPS in Rs	11.92	-18.36	1.31	4.32	8.19	7.50	-1.49	-1.69	37.47	1.55

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	699	815	1,180	1,104	1,235	1,270	1,343	1,705	2,111	2,202
Expenses	739	946	1,264	1,155	1,144	1,197	1,389	1,605	1,846	2,018
Operating Profit	-40	-131	-83	-51	91	73	-46	100	265	184
OPM %	-5.79	-16.14	-7.08	-4.60	7.38	5.73	-3.39	5.88	12.55	8.36
Other Income	5.69	61	98	92	50	46	-0.05	-26	35	265
Interest	3.36	8.01	7.52	7.85	5.12	6.11	17	23	21	32
Depreciation	44	51	67	82	84	91	113	113	125	125
Profit Before Tax	-83	-130	-60	-48	51	22	-176	-62	155	292
Tax %	14.35	-2.58	57.34	-24.83	33.32	-50.49	-14.67	-14.28	11.04	13.52
Net Profit	-71	-133	-26	-60	34	33	-202	-70	138	253
EPS in Rs	—	—	-4.26	-8.54	4.88	4.68	-28.72	-10.01	21.32	35.84
Dividend Payout %	25.13	1.78	-118.34	-46.78	81.97	85.47	-13.93	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	18	14	14	14	14	14	14	14	14	14
Reserves	1,045	2,666	2,606	2,517	2,543	2,604	2,421	2,348	2,437	2,703
Borrowings	98	151	200	207	119	349	314	248	460	500
Other Liabilities	365	363	330	407	450	351	444	559	659	520
Total Liabilities	1,527	3,194	3,150	3,145	3,126	3,319	3,193	3,169	3,569	3,737
Fixed Assets	487	574	806	866	880	990	1,257	1,196	1,300	1,213
CWIP	250	238	92	330	567	494	147	123	31	100
Investments	18	905	930	553	396	264	1.70	1.36	0.02	0.02
Other Assets	772	1,476	1,321	1,395	1,282	1,571	1,787	1,849	2,239	2,425
Total Assets	1,527	3,194	3,150	3,145	3,126	3,319	3,193	3,169	3,569	3,737

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	68	-112	-328	20	33	-260	-85	17	-7.02	3.64
Cash from Investing Activity	-128	1,648	-286	-36	-66	102	239	50	-241	192
Cash from Financing Activity	59	-881	-2.42	-62	-121	191	-81	-106	184	1.86
Net Cash Flow	-0.46	655	-616	-78	-154	34	73	-39	-64	198

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	70.21%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%	70.22%
FIIs	0.83%	0.84%	0.90%	0.89%	0.94%	1.06%	0.98%	0.98%	1.00%	0.99%	1.00%	0.90%
DIIs	10.32%	10.75%	11.27%	11.58%	11.67%	11.63%	11.32%	10.92%	10.75%	10.74%	10.63%	10.46%
Public	18.64%	18.18%	17.61%	17.30%	17.18%	17.09%	17.48%	17.88%	18.03%	18.05%	18.15%	18.42%
Total Shareholders	21,584	20,877	21,171	20,621	20,374	21,472	21,621	23,010	23,577	23,267	23,386	25,347

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY17

Investor Presentation

Q3 FY17

Investor Presentation

Q2 FY17

Investor Presentation

Q1 FY17

Investor Presentation

Q4 FY16

Investor Presentation

Q3 FY16

Actions

Action Type

‌
‌

Announcements

Last 7 days

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Unichem Laboratories Ltd

Unichem Laboratories Ltd (UNICHEMLAB) is currently trading at 539.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients and operates through four divisions. It has five manufacturing facilities across India, enjoying numerous global certifications. The company has a rich history of collaborations and initiatives, having set up various R&D centers and strategic plants since its inception in 1962, illustrating its commitment to growth and innovation. Recent strategic moves include a significant acquisition by Ipca Laboratories Limited, which now holds majority control over Unichem, influencing its future trajectory and operational strategies. Despite divesting some business components in the past, Unichem continues to expand its international presence, notably with a wholly owned subsidiary in China, reflecting its global ambitions.

Over the past 52 weeks, Unichem Laboratories Ltd has traded between a low of ₹280.00 and a high of ₹685.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Unichem Laboratories Ltd has a market capitalization of approximately 3,796.63. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Unichem Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 46.37 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 3,796.63 Cr, Unichem Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Unichem Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Unichem Laboratories Ltd is 46.37. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Unichem’s consolidated Q4 net profit was ₹11 crore, down from ₹53 crore in the same quarter last year, a 79.2% year-on-year decline.

Unichem Laboratories Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Oscillators

Neutral

Overall

Bullish

Moving Averages

Bullish

Overall

Bullish

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Unichem Laboratories Ltd

What is Unichem Laboratories Ltd share price today?

What does Unichem Laboratories Ltd do?

What is the 52-week high and low of Unichem Laboratories Ltd?

What is the market capitalization of Unichem Laboratories Ltd?

Should I consider investing in Unichem Laboratories Ltd stock?

Is Unichem Laboratories Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Unichem Laboratories Ltd belong to and why does it matter?

What is the PE ratio of Unichem Laboratories Ltd?

What was Unichem Laboratories’ Q4 net profit and how did it compare YoY?

Investor's Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Overview

Financial Ratios

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Forecasts

Peers

Price Chart Comparison

Frequently Asked Questions about Unichem Laboratories Ltd

What is Unichem Laboratories Ltd share price today?

What does Unichem Laboratories Ltd do?

What is the 52-week high and low of Unichem Laboratories Ltd?

What is the market capitalization of Unichem Laboratories Ltd?

Should I consider investing in Unichem Laboratories Ltd stock?

Is Unichem Laboratories Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Unichem Laboratories Ltd belong to and why does it matter?

What is the PE ratio of Unichem Laboratories Ltd?

What was Unichem Laboratories’ Q4 net profit and how did it compare YoY?

Projection

Investment Checklist

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Announcements